Zobrazeno 1 - 10
of 30
pro vyhledávání: '"vaccine potency testing"'
Publikováno v:
Biomolecules, Vol 11, Iss 3, p 407 (2021)
The antigenic variability of influenza presents many challenges to the development of vaccines and immunotherapeutics. However, it is apparent that there are epitopes on the virus that have evolved to remain largely constant due to their functional i
Externí odkaz:
https://doaj.org/article/fd9a4e08f11d4b9193c5b2a02519a293
Publikováno v:
Biomolecules, Vol 11, Iss 407, p 407 (2021)
Biomolecules
Biomolecules
The antigenic variability of influenza presents many challenges to the development of vaccines and immunotherapeutics. However, it is apparent that there are epitopes on the virus that have evolved to remain largely constant due to their functional i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db46652f81caf412e66fa90f0d05fbc
https://doi.org/10.3390/biom11030407
https://doi.org/10.3390/biom11030407
Autor:
Coenraad F.M. Hendriksen
Publikováno v:
Procedia in Vaccinology. 5:221-226
Vaccine potency and safety testing is characterized by extensive use of laboratory animals and a relatively high percentage of test methods that involve severe pain and distress. This is particularly true for tests that are based on infection or chal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cd8eb9ed952d1caae77e9a6684624db
Autor:
Brett Jones, Jodie Kulpa-Eddy, Vivian W. Doelling, Ivo Claassen, Glen Gifford, Jeffrey Galvin, Karen Brown, James Roth, Marlies Halder, Geetha Srinivas, Ralph Woodland, William S. Stokes, Richard Hill, Hans Draayer
Publikováno v:
Procedia in Vaccinology
NICEATM and ICCVAM convened an international workshop to review the state of the science of human and veterinary vaccine potency and safety testing methods and to identify opportunities to advance new and improved methods that can further reduce, ref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157f7788a8195f999f1904827e201b2d
https://doi.org/10.1016/j.provac.2011.10.005
https://doi.org/10.1016/j.provac.2011.10.005
Autor:
David Allen, Dorothea Sesardic, Michael P. Schmitt, Yoshinobu Horiuchi, Paul Stickings, Johan Descamps, Warren Casey, Daniela Verthelyi, Richard Isbrucker, Elizabeth A. Lipscomb, Nelson W Johnson, Juan Arciniega, Richard McFarland, Theresa M. Finn
Publikováno v:
Procedia in Vaccinology
NICEATM and ICCVAM convened an international workshop to review the state of the science of human and veterinary vaccine potency and safety testing methods, and to identify opportunities to advance new and improved methods that can further reduce, re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb6121b8a062f07d6c55e0e63e311c7
https://doi.org/10.1016/j.provac.2011.10.002
https://doi.org/10.1016/j.provac.2011.10.002
Autor:
Glen Gifford, Ralph Woodland, William S. Stokes, Hans Draayer, Brett Jones, Ivo Claassen, Jeffrey Galvin, Jodie Kulpa-Eddy, Geetha Srinivas, Vivian W. Doelling, Karen Brown, Marlies Halder
Publikováno v:
Procedia in Vaccinology. 5:84-105
Veterinary vaccines contribute to improved human and animal health and welfare by preventing diseases and deaths caused by a wide range of infectious agents. However, testing necessary to ensure vaccine effectiveness and safety can involve large numb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc25ac2e7560402c660b0460fb9b89e
Autor:
Theresa M. Finn
Publikováno v:
Procedia in Vaccinology. 5:137-140
The Office of Vaccines Research and Review (OVRR) at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) regulates preventative and therapeutic vaccines for infectious disease indications for use in humans. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9165bd48a1f952c2eac1fd8815df1806
https://doi.org/10.1016/j.provac.2011.10.010
https://doi.org/10.1016/j.provac.2011.10.010
Autor:
Schiffelers, Marie-Jeanne W. A., Blaauboer, Bas J., Bakker, Wieger E., Hendriksen, Coenraad F. M., Public Management, LS IRAS Tox CMT/ATX, Dep Bestuurs- en Organisatiewetenschap, Public Governance, Sub 3V Centrum ULS, Risk Assessment of Toxic and Immunomodulatory Agents, IRAS RATIA1, UU LEG Research USG Public Matters
Publikováno v:
ALTEX-Alternatives to Animal Experimentation, 32(3), 211. Springer International Publishing AG
In April 2013 the mouse antibody serum neutralization test (SNT) was formally incorporated into European Pharmacopoeia monograph 0451 for potency testing of inactivated veterinary rabies vaccines. The SNT is designed to replace the highly variable an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::750ac5605c75f524e81ab3f521fa02a8
https://pubmed.ncbi.nlm.nih.gov/26536289
https://pubmed.ncbi.nlm.nih.gov/26536289
De introductie van humane eindpunten is gericht op het verminderen van pijn en ongerief bij proefdieren. Vaccin controle testen, zoals vastgelegd in de Europese Farmacopee, zijn vaak gebaseerd op immunisatie-challenge procedures in proefdieren, waarb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::16f9ea985ce069f1d12f3893ccfcdb73
De introductie van humane eindpunten is gericht op het verminderen van pijn en ongerief bij proefdieren. Vaccin controle testen, zoals vastgelegd in de Europese Farmacopee, zijn vaak gebaseerd op immunisatie-challenge procedures in proefdieren, waarb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::4d69287868c5af0d0041370af2c5d403
http://hdl.handle.net/10029/260229
http://hdl.handle.net/10029/260229